Marra Andrea
Università Campus Bio-Medico di Roma, Roma, Italy.
Research Interests: acute myeloid leukemia, lymphomas, tumor microenvironment, tumor immunology, cancer immunotherapy.
Bernhard Biersack 
Organic Chemistry Laboratory, University of Bayreuth, Bayreuth, Germany.
Research Interests: medicinal chemistry, drug design, epigenetics, metal-based drugs, alkylating agents, tubulin-binding drugs, kinase inhibitors, HDAC inhibitors.
Ilana Chefetz
Hormel Institute, University of Minnesota, Austin, MN, USA.
Research Interests: ovarian cancer, cell death, necroptosis, cancer stem cells, chemoresistance, metabolism, DNA damage and repair, ovary and brain.
Zhencong Chen
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Research Interests: lung adenocarcinoma, non-small cell lung cancer, drug resistance, thoracic cancer.
Qian Chen
The Fourth People's Hospital Affiliated to Tongji University, Shanghai, China.
Research Interests: nanocatalysis, tumor therapy.
Ivy Chung
Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Research Interests: cancer therapeutics, tumor microenvironment, cancer-associated fibroblasts, drug pharmacology, drug resistance.
Xingliang Dai
Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Research Interests: glioma, nano-medicine, 3D Bioprinting, radio-and chemo-therapy resistance.
Jessica Dal Col
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Fisciano (SA), Italy
Research Interests: lung cancer, EGFR-TKI resistance, RNA-binding proteins, immune evasion, cell cycle, apoptosis, autophagy, phospholipid scramblase 1, signaling pathway.
Dechao Feng
Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Research Interests: identifying prognostic biomarkers, big data multi-omics analysis, aging, immunology, nanomaterials, drug-related aspects of cancer rehabilitation.
Alessandra Ferraresi
Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Research Interests: autophagy, tumor microenvironment, cell metabolism, dormancy, nutraceutics, epigenetics, 3D models, personalized cancer therapy.
Ana Rita Figueiras
Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Research Interests: micelleplexes, polymeric micelles, nanomedicine, nanotechnology, gene therapy, cyclodextrins, mucoadhesive polymers.
Natalie R. Gassman
Department of Physiology and Cell Biology, University of South Alabama College of Medicine, Mobile, AL, USA.
Research Interests: triple negative breast cancer, DNA damage, DNA repair, base excision repair.
Gunnel Halldén
Barts and The London School of Medicine and Dentistry, London, UK.
Research Interests: virotherapy, oncolytic adenovirus, combination therapies, small molecule inhibitors, cancer cell biology, cancer resistance, prostate cancer, pancreatic cancer, in vivo studies.
Jian He
Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: single-cell multi-omics technology, tumor immune microenvironment, tumor biomarkers and targets, virtual drug screening and repositioning.
Xin Hong
Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Research Interests: circulating tumor cells (CTCs), liquid biopsy, cancer metastasis, non-invasive biomarkers.
Sachi Horibata
Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Research Interests: cancer drug resistance, cancer biology, genomics, precision oncology.
Lipeng Hu
Shanghai Jiao Tong University Shanghai Cancer Institute, Shanghai, China.
Research Interests: metabolism reprogramming in tumor microenvironment including tumor cells, stromal cells, immune cells.
Jie Huang
Guangdong Provincial People’s Hospital, Guangzhou, Guangdong, China.
Research Interests: Lung cancer, Small Cell Lung Cancer (SCLC), EGFR mutation, drug resistance in lung cancer, immune checkpoint inhibitors
Shanzhou Huang
Guangdong Provincial People’s Hospital, Guangzhou, Guangdong, China.
Research Interests: liver cancer, ferroptosis, epigenetics, drug resistance, post-translational modification proteomics, cell death, treatment
Tamara Ius
Head-Neck and NeuroScience Department University Hospital of Udine, Udine, Italy
Research Interests: glioma; immunotherapy; tumor microenvironment; liquid biopsy; radiotherapy; chemotherapy; tumor recurrence; extent of resection; malignant transformation; epilepsy
Parvez Khan
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Research Interests: cancer biology, lung cancer, brain metastasis, chemotherapeutic resistance, cancer therapeutics, cancer metabolism, protein kinases, molecular biophysics, small molecule inhibitors, structure-based drug design and discovery.
Joanna Kopecka
Department of Oncology, University of Torino, Torino, Italy.
Research Interests: chemoresistance, immunoresistance, cancer metabolism, stem cells, inflammation, ER stress, new cancer models, new therapeutic approaches.
Yuehua Li
The First Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Research Interests: chest tumor, malignant tumor metastasis, drug resistance.
Ke Li
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Research Interests: basic and clinical translational of Leukemia, malignant hematologic system tumors, breast cancer, and liver cancer.
Yuanfang Li
Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: gastric cancer, immunotherapy, tumor microenvironment, drug resistance, metastasis, tumor-immune interactions.
Yingjie Li
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
Research Interests: molecular mechanisms, immunotherapy of drug resistance, drug discovery and development.
Dengxiong Li
West China School of Medicine/West China Hospital of Sichuan University, Chengdu, China
Research Interests: tumor immune microenvironment, methylated modification, biomarkers, chemoresistance, clinical therapy and drugs development in urological tumors
Xian Lin
Hong Kong University of Science and Technology Medical Center, Peking University, Shenzhen, China.
Research Interests: natural compounds, oncology, immunology, epigenetic modification, signal transduction, bioinformatics, non-coding RNA.
Xiaoxiao Liu
Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Research Interests: cancer immunology, gene immunotherapy, anticancer therapy, liver injury and inflammatory.
Hengrui Liu
University of Cambridge, Cambridge, UK.
Research Interests: cancer biomarker, ion channels
Alan P Lombard
Department of Urologic Surgery, Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, USA.
Research Interests: prostate cancer, therapeutic resistance, treatment response, drug tolerant persistence, PARP inhibition, AR pathway inhibitors, precision medicine, rational combination therapy.
Weiwen Long
Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA.
Research Interests: growth factor signaling, steroid receptor/coactivator signaling, the interplay between these two signaling pathways in cancer progression and metastasis.
Peng Luo
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Research Interests: antitumor pharmacogenomics, tumor immune microenvironment.
Liying Ma
School of Pharmacy, Zhengzhou University, Zhengzhou, Henan, China.
Research Interests: targeted drug discovery and mechanism research.
Wei Ma
Jiangnan University, Wuxi, Jiangsu, China.
Research Interests: preparation of nano-biological probes; tumor marker detection and treatment.
Nicola Manfrini
Department of Biosciences, University of Milan, Milan, Italy; National Institute of Molecular Genetics (INGM) “Romeo and Enrica Invernizzi”, Milan, Italy.
Research Interests: cancer biology, cancer drug resistance, autophagy, apoptosis, translation modulation, single-cell analysis, multiple myeloma, breast cancer.
Wenjun Mao
The affiliated Wuxi people’s hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
Research Interests: application of biomaterials in medical field, basic and clinical research of lung cancer, tumor exosomes, tumor immune microenvironment, tumor immunotherapy, tumor biology, bioinformatic.
Elena Mariotto
Department of Woman’s and Child’s Health, University of Padova, Padova, Italy.
Research Interests: high throughput drug screening (HTS), medulloblastoma, acute lymphoblastic leukemia, pediatric cancer, cell cycle, apoptosis, kinase inhibitors.
Chiara Martinelli
Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.
Research Interests: cancer, theragnostics, targeted therapy, nanotechnology, nanomedicine, multifunctional nanomaterials, nanocarriers, drug delivery.
Lingbin Meng
The Ohio State University Comprehensive Cancer Center, Columbus, United States
Research Interests: prostate cancer, bladder cancer, kidney cancer, immunotherapy, drug resistance, translational therapeutics, clinical trials, cell therapy, gene therapy/target therapy
Cristina Minnelli
Organic Chemistry Laboratory, Department of Life and Environmental Sciences, University Polytechnic of Marche, Ancona, Italy.
Research Interests: lung cancer, epidermal growth factor receptor (EGFR), tyrosine kinase inhibitors (TKIs), structure-based drug design, TKIs resistance, non-small cell lung cancer.
Runcong Nie
Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: gastric cancer, immunotherapy, tumor microenvironment, drug resistance, metastasis,tumor-immune interactions.
Fu Peng
West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China.
Research Interests: oncology, tumor microenvironment, natural products, non-coding RNA, regulated cell death.
Cristina Pinto Ribeiro Xavier
Cancer Drug Resistance Group, i3S - Instituto de Investigação e Inovação em Saúde, IPATIMUP - Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Research Interests: drug discovery, pancreatic cancer, lung cancer, cancer drug resistance, cancer therapy, cancer biology, extracellular vesicles.
Feifei Pu
Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No.1 Hopital),
Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Research Interests: bone tumor diagnosis and treatment of traditional Chinese and Western medicine, traditional Chinese medicine tumor research
Qiang Qu
Xiangya Hospital Central South University, Changsha, China.
Research Interests: cancer, drug resistance, epigenetics, pharmacology, pharmacogenetics, metabolic reprogramming, super-enhancer, leukemia, stem cell, immunotherapy, liquid tumor biopsy
Ming Quan
Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Research Interests: colonrectal cancer; pancreatic cancer; tumor microenvironment;immunotherapy targeted therapy; tumor metabolism; tumor immunity; cancer-associated fibroblasts; Her2(human epidermal growth factor receptor)
Faisal Raza
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Research Interests: cancer, targeted drug delivery, tumor microenvironment, cancer nanomedicine, biomimetic nanotechnology, biomaterials, drug resistance.
Giandomenico Roviello
Department of Health Sciences, University of Florence, Florence, Italy.
Research Interests: immunotherapy, prostate cancer, gastric cancer, renal cell carcinoma, chemotherapy.
Ravi Sahu
Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University, Dayton, OH, USA.
Research Interests: oxidative stressors and lipid mediators, cancer pharmacology and chemoprevention, anti-cancer agents and immunomodulation, cellular signaling pathways in tumor resistance mechanisms.
Iris Chiara Salaroglio
Department of Oncology, University of Turin, Turin, Italy.
Research Interests: MDR, oncology, chemoresistance, immunoresistance, drug response.
Luigi Sapio
Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Research Interests: Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), naturally occurring molecules, lipid metabolism, Cancer Therapy and Resistance, Cancer Metabolism.
Ying Shen
Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: molecular targeted therapy for lung cancer drug resistance, tumor metastasis, tumor pharmacology, tumor metabolism.
Tingyan Shi
Zhongshan Hospital, Fudan University, Shanghai, China.
Research Interests: cervical cancer, ovarian cancer, uterine fibroids, ovarian tumors.
Santosh Singh
Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, USA.
Research Interests: targeted therapy, nanotherapy, multidrug resistance, drug delivery, combination therapy, prostate cancer, breast cancer, ovarian cancer.
Bufu Tang
Zhejiang University School of Medicine, Hangzhou, China.
Research Interests: molecular imaging and drug delivery, cellular iron death, the crosstalk of the immune microenvironment
Abhishek Tyagi
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Research Interests: tumor microenvironment, cancer immunotherapy, breast and lung cancer, tumor metastasis, non-coding RNAs, cancer stem cells and radioresistance.
Yumin Wang
Aerospace Center Hospital/Peking University Aerospace School of Clinical Medicine, Beijing, China.
Research Interests: regulated cell death and cancer drug resistance.
Ling Wang
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Research Interests: computer-aided drug design, artificial intelligence-aided
drug discovery and medicinal chemistry, the design and
discovery of kinase inhibitors.
Jingquan Wang
Department of Pharmaceutical Sciences, St. John’s University, Queens, NY, USA.
Research Interests: multidrug resistance, cancer pharmacology, molecular modeling, ABC transporters, drug repurposing, virtual drug screening.
Hongquan Wang
Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Research Interests: regulated cell death, cancer drug resistance.
Jingya Wang
Department of Cancer Center, Houston Methodist, Houston, TX, USA.
Research Interests: myltiple myeloma, epigenetics, immunotherapy, cancer immunology, gamma delta T cells, CAR-T.
Zheng Wang
Comprehensive Breast Health Center, Ruijin Hospital and Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: oncology, cancer metastasis, tumor microenvironment, breast cancer, immunotherapy, metabolic reprogramming, novel target, interventional strategy, clinical pattern, predictive model.
Junlong Wu
Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Research Interests: prostate cancer, urothelial carcinoma, genetics and genomics, castration resistant, biomarker, chemotherapy resistant, immunotherapy resistant.
Chenglai Xia
Foshan Maternity and Chlid Healthcare Hospital, Foshan, Guangdong, China.
Research Interests: cancer drug resistance, small-molecule agents for cancer immunotherapy, intratumoral microbiota and drug interactions.
Wen Xiao
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China.
Research Interests: renal cancer, prostate cancer, bladder tumor, tumorigenesis.
Feifei Yang
Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Research Interests: tumor microenvironment, tumor initiation, tumor progression, mechanisms, translational research.
Min Yu
Guangdong Provincial People’s Hospital, Guangzhou, Guangdong, China.
Research Interests: chemoresistance of pancreatic Cancer, DNA damage repair, tumor microenvironment
Giorgia Zadra
Institute of Molecular Genetics, National Research Council, Pavia, Italy.
Research Interests: prostate cancer, cancer metabolism, metabolic imaging, metabolomics, diet & lipid metabolism, cancer microenvironment, resistance to endocrine therapies, cancer progression.
Marco Zeppieri
University Hospital of Udine, Udine, Italy
Research Interests: ophthalmology; melanoma; mesenchymal stem cell; regenerative therapies; intraocular pressure; tonometry; ocular surface disease; eyes; visual fields; clinical ophthalmology
Jianye Zhang
School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
Research Interests: tumor biology, novel technology application in cancer research, anticancer agents from natural products.
Qun Zhang
Nanjing Drum Tower Hospital, Nanjing, China.
Research Interests: colorectal cancer, immunotherapy, targeted therapy
Daniel Xin Zhang
Department of Health Sciences, Hong Kong Metropolitan University, Hongkong, China.
Research Interests: cancer biology in metastasis and progression, nanoscale bioengineering (extracellular vesicles), molecular pathology (RNA & member proteins), novel cancer diagnostics and therapeutics.
Xiangxuan Zhao
Department of Radiology, Shengjing Hospital of China Medical University, Liaoning, China.
Research Interests: natural products, cancer resistance, cancer biology, apoptosis, immunotherapy, exosomes, epigenetics.
Wei Zhao
Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Guangzhou, China.
Research Interests: cancer epigenetics, histone modification and RNA methylation in cancers, single-cell analysis of tumor environment.
Fei Zhou
Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Research Interests: the discovery of biomarkers, novel therapeutic strategies of immunotherapy and targeted therapy of lung cancer, including patients with rare thoracic cancers, such as pulmonary sarcomotoid carcinoma, pulmonary large cell neuroendocrine carcinoma, et al.
Yutian Zou
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: breast cancer, tumor microenvironment, immunotherapy, antibody-drug conjugates, HER2, Single-cell sequencing, CRISPR screen, circular RNA, cell death
.png)
